These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 20167147

  • 1. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis.
    Katial RK, Oppenheimer JJ, Ostrom NK, Mosnaim GS, Yancey SW, Waitkus-Edwards KR, Prillaman BA, Ortega HG.
    Allergy Asthma Proc; 2010; 31(1):68-75. PubMed ID: 20167147
    [Abstract] [Full Text] [Related]

  • 2. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.
    Nathan RA, Yancey SW, Waitkus-Edwards K, Prillaman BA, Stauffer JL, Philpot E, Dorinsky PM, Nelson HS.
    Chest; 2005 Oct; 128(4):1910-20. PubMed ID: 16236835
    [Abstract] [Full Text] [Related]

  • 3. Adherence to asthma controller medication regimens.
    Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 5. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
    Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, Ditta V, Martinelli N, Candore G, Mansueto P, Rini GB, Corrocher R, Caruso C.
    Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306
    [Abstract] [Full Text] [Related]

  • 6. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.
    Martin BG, Andrews CP, van Bavel JH, Hampel FC, Klein KC, Prillaman BA, Faris MA, Philpot EE.
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):851-7. PubMed ID: 16802774
    [Abstract] [Full Text] [Related]

  • 7. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004 Jun; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 8. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
    Pearlman DS, White MV, Lieberman AK, Pepsin PJ, Kalberg C, Emmett A, Bowers B, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):227-35. PubMed ID: 11868930
    [Abstract] [Full Text] [Related]

  • 9. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone.
    Katial RK, Bernstein D, Prazma CM, Lincourt WR, Stempel DA.
    Allergy Asthma Proc; 2011 Feb; 32(2):127-36. PubMed ID: 21189151
    [Abstract] [Full Text] [Related]

  • 10. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD, Stanford R, Crim C, Yancey SW, Edwards L, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [Abstract] [Full Text] [Related]

  • 11. Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".
    Koenig SM, Ostrom N, Pearlman D, Waitkus-Edwards K, Yancey S, Prillaman BA, Dorinsky P.
    J Asthma; 2008 Oct; 45(8):681-7. PubMed ID: 18951261
    [Abstract] [Full Text] [Related]

  • 12. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.
    Pullerits T, Praks L, Ristioja V, Lötvall J.
    J Allergy Clin Immunol; 2002 Jun; 109(6):949-55. PubMed ID: 12063523
    [Abstract] [Full Text] [Related]

  • 13. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
    Ratner PH, Howland WC, Arastu R, Philpot EE, Klein KC, Baidoo CA, Faris MA, Rickard KA.
    Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135
    [Abstract] [Full Text] [Related]

  • 14. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
    O'Connor RD, Gilmore AS, Manjunath R, Stanford RH, Legorreta AP, Jhingran PM.
    Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
    Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
    Sheth K, Borker R, Emmett A, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2002 Apr; 20(13):909-18. PubMed ID: 12381242
    [Abstract] [Full Text] [Related]

  • 17. Randomized comparison of strategies for reducing treatment in mild persistent asthma.
    American Lung Association Asthma Clinical Research CentersWake Forest University, Winston-Salem, NC, USA., Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ, Wise RA.
    N Engl J Med; 2007 May 17; 356(20):2027-39. PubMed ID: 17507702
    [Abstract] [Full Text] [Related]

  • 18. Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone.
    Calhoun WJ, Nelson HS, Nathan RA, Pepsin PJ, Kalberg C, Emmett A, Rickard KA, Dorinsky P.
    Am J Respir Crit Care Med; 2001 Sep 01; 164(5):759-63. PubMed ID: 11549529
    [Abstract] [Full Text] [Related]

  • 19. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.
    Eur Ann Allergy Clin Immunol; 2003 Nov 01; 35(9):356-62. PubMed ID: 14716965
    [Abstract] [Full Text] [Related]

  • 20. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR.
    J Allergy Clin Immunol; 2004 Feb 01; 113(2):245-51. PubMed ID: 14767437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.